However, Rho GTPase activating protein 5 (ARHGAP5) was identified as an oncogene that affected cell migration and invasion in cervical cancer 50, gastric cancer 51 and nasopharyngeal carcinoma 52. Here, ARHGAP5 is linked to nasopharyngeal carcinoma.